MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

被引：0

作者：

Bean, James ^{[1
]}

Brennan, Cameron ^{[1
]}

Shih, Jin-Yuan ^{[2
]}

Riely, Gregory ^{[1
]}

Viale, Agnes ^{[1
]}

Wang, Lu ^{[1
]}

Chitale, Dhananjay ^{[1
]}

Motoi, Noriko ^{[1
]}

Szoke, Janos

Broderick, Stephen

Balak, Marissa ^{[1
]}

Chang, Wen-Cheng ^{[3
]}

Yu, Chong-Jen ^{[1
,2
]}

Gazdar, Adi ^{[4
]}

Pass, Harvey ^{[5
]}

Rusch, Valerie ^{[1
]}

Gerald, William ^{[1
]}

Huang, Shiu-Feng ^{[6
]}

Yang, Pan-Chyr ^{[2
]}

Miller, Vincent ^{[1
]}

Ladanyi, Marc ^{[1
]}

Yang, Chih-Hsin

Pao, William ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, New York, NY USA

[2] Natl Taiwan Univ Hosp, Taipei, Taiwan

[3] Chang Gung Mem Hosp, Tao Yuan, Taiwan

[4] Univ Texas SW Med Ctr Dallas, Dallas, TX USA

[5] NYU Med Ctr, New York, NY USA

[6] Natl Inst Hlth Res, Miaoli, Taiwan

来源：

MOLECULAR CANCER THERAPEUTICS | 2007年 / 6卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3333S / 3334S

页数：2

共 50 条

[1] MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib
Bean, James
Brennan, Cameron
Shih, Jin-Yuan
Riely, Gregory
Viale, Agnes
Wang, Lu
Chitale, Dhananjay
Motoi, Noriko
Szoke, Janos
Broderick, Stephen
Balak, Marissa
Chang, Wen-Cheng
Yu, Chong-Jen
Gazdar, Adi
Pass, Harvey
Rusch, Valerie
Gerald, William
Huang, Shiu-Feng
Yang, Pan-Chyr
Miller, Vincent
Ladany, Marc
Yang, Chih-Hsin
Pao, William
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (52) : 20932 - 20937
[2] Reciprocal and Complementary Role of MET Amplification and EGFR T790M Mutation in Acquired Resistance to Kinase Inhibitors in Lung Cancer
Suda, Kenichi
Murakami, Isao
Katayama, Tatsuya
Tomizawa, Kenji
Osada, Hirotaka
Sekido, Yoshitaka
Maehara, Yoshihiko
Yatabe, Yasushi
Mitsudomi, Tetsuya
[J]. CLINICAL CANCER RESEARCH, 2010, 16 (22) : 5489 - 5498
[3] Challenges of detecting EGFR T790M in gefitinib/erlotinib-resistant tumours
Jaenne, Pasi A.
[J]. LUNG CANCER, 2008, 60 : S3 - S9
[4] EGFR L718Q mutation occurs without T790M mutation in a lung adenocarcinoma patient with acquired resistance to osimertinib
Ma, Lei
Chen, Rui
Wang, Fang
Ma, Li-Li
Yuan, Ming-Ming
Chen, Rong-Rong
Liu, Jiang
[J]. ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (09)
[5] Acquired resistance to gefitinib: The contribution of mechanisms other than the T790M, MET, and HGF status
Onitsuka, Takamitsu
Uramoto, Hidetaka
Nose, Naohiro
Takenoyama, Mitsuhiro
Hanagiri, Takeshi
Sugio, Kenji
Yasumoto, Kosei
[J]. LUNG CANCER, 2010, 68 (02) : 198 - 203
[6] Acquired T790M resistance do afatinib in EGFR mutated lung adenocarcinoma
Miyazaki, Kunihiko
Sato, Shinya
Kodama, Takahide
Satoh, Hiroaki
Hizawa, Nobuyuki
[J]. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2016, 64 (04): : 317 - 318
[7] Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
D Ercan
K Zejnullahu
K Yonesaka
Y Xiao
M Capelletti
A Rogers
E Lifshits
A Brown
C Lee
J G Christensen
D J Kwiatkowski
J A Engelman
P A Jänne
[J]. Oncogene, 2010, 29 : 2346 - 2356
[8] Lung adenocarcinoma with good response to erlotinib after gefitinib treatment failure and acquired T790M mutation
Wu, Shang-Gin
Shih, Jin-Yuan
Yu, Chong-Jen
Yang, Pan-Chyr
[J]. JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (04) : 451 - 452
[9] Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
Ercan, D.
Zejnullahu, K.
Yonesaka, K.
Xiao, Y.
Capelletti, M.
Rogers, A.
Lifshits, E.
Brown, A.
Lee, C.
Christensen, J. G.
Kwiatkowski, D. J.
Engelman, J. A.
Jaenne, P. A.
[J]. ONCOGENE, 2010, 29 (16) : 2346 - 2356
[10] Suppression of gefitinib-induced EMT in EGFR mutant NSCLC preferentially selects for acquired T790M
Soucheray, Margaret
Capelletti, Marzia
Pulido, Ines
Kuang, Yunan
Paweletz, Cloud P.
Becker, Jeffrey H.
Kikuchi, Eiki
Xu, Chunxiao
Patel, Tarun B.
Al-shahrour, Fatima
Carretero, Julian
Wong, Kwok-Kin
Janne, Pasi A.
Shapiro, Geoffrey I.
Shimamura, Takeshi
[J]. CANCER RESEARCH, 2015, 75

← 1 2 3 4 5 →